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The Calcium-Sensing Receptor and
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and Migration
Sujeenthar Tharmalingam † and David R. Hampson*
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The calcium-sensing receptor (CaSR) is a widely expressed homodimeric G-protein
coupled receptor structurally related to the metabotropic glutamate receptors and
GPRC6A. In addition to its well characterized role in maintaining calcium homeostasis
and regulating parathyroid hormone release, evidence has accumulated linking the CaSR
with cellular differentiation and migration, brain development, stem cell engraftment,
wound healing, and tumor growth and metastasis. Elevated expression of the
CaSR in aggressive metastatic tumors has been suggested as a potential novel
prognostic marker for predicting metastasis, especially to bone tissue where extracellular
calcium concentrations may be sufficiently high to activate the receptor. Recent
evidence supports a model whereby CaSR-mediated activation of integrins promotes
cellular migration. Integrins are single transmembrane spanning heterodimeric adhesion
receptors that mediate cell migration by binding to extracellular matrix proteins. The CaSR
has been shown to form signaling complexes with the integrins to facilitate both the
movement and differentiation of cells, such as neurons during normal brain development
and tumor cells under pathological circumstances. Thus, CaSR/integrin complexes may
function as a universal cell migration or homing complex. Manipulation of this complex
may be of potential interest for treating metastatic cancers, and for developmental
disorders pertaining to aberrant neuronal migration.
Keywords: calcium, extracellular matrix, G-protein coupled receptor, GPRC6A, cerebellum, cerebellar granule
cells, metastasis, medulloblastoma
INTRODUCTION—GENERAL FEATURES OF CaSR STRUCTURE,
ACTIVATION, AND EXPRESSION
The CaSR belongs to the metabotropic glutamate receptor subclass of G-protein coupled receptors
(GPCRs). In addition to the eight metabotropic glutamate receptor subtypes, other members of
this relatively small GPCR subfamily include the GABAB receptor, several taste receptors, and
GPRC6A (reviewed in Conigrave and Hampson, 2010). Among these family members, the CaSR
has particularly high homology, in terms of both protein sequence (31% amino acid identity) and
gene structure, with GPRC6A (Kuang et al., 2005). Interestingly, GPRC6A is activated directly
by several amino acids, the most potent of which are arginine and lysine, and is allosterically
potentiated by extracellular Ca2+ (Kuang et al., 2005; Wellendorph et al., 2005), whereas the CaSR
is activated directly by Ca2+ and allosterically modulated by amino acids (Conigrave et al., 2000).
This similar but reciprocal pharmacological relationship is likely a reflection of the evolutionary
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origins of the two receptors (Kuang et al., 2006). The close
relationship between these two GPCRs is further illustrated by
reports that both receptors are activated by multiple endogenous
ligands (see Clemmensen et al., 2014 for review). For example,
in addition to amino acids, GPRC6A is also activated by
testosterone (Ko et al., 2014), and some groups have reported
that osteocalcin, a bone-derived peptide that participates in
pancreatic beta cell function, is also an endogenous ligand (Pi
et al., 2011; De Toni et al., 2014; Wei et al., 2014); although this
remains controversial (see Rueda et al., 2016).
The CaSR is a large heptahelical transmembrane glycoprotein
consisting of 1078 amino acids with a molecular weight of
approximately 120 kilodaltons. Like other members of the
metabotropic glutamate receptor family, it likely exists in the
plasmamembrane in a dimeric configuration (Bai et al., 1999; Hu
and Spiegel, 2007). In most cases the cellular event that initiates
activation of the receptor is a rise in extracellular Ca2+. However,
in addition to Ca2+ ions the receptor can also be activated by
a several other di- and trivalent cations and organic molecules
such as the polyamines (Leach et al., 2014), some of which likely
operate as additional or alternative endogenous ligands. A salient
feature of this receptor is that it contains multiple Ca2+ binding
sites within the active oligomeric complex and displays a high
degree of positive cooperativity of activation (Breitwieser, 2013).
In functional biochemical assays, the Hill coefficient of activation
is typically 4–6 (Miedlich et al., 2002; Tharmalingam et al., 2011;
Conigrave and Ward, 2013) and up to five Ca2+ binding sites
have been predicted for the receptor (Zhang et al., 2014). The
presence of multiple cation binding sites operating in a highly
positive cooperative fashion translates into a state whereby small
changes within a narrow concentration range of extracellular
Ca2+ (1.1–1.3mM) fully and rapidly activates the receptor.
The CaSR has been linked to a wide range of physiological
processes. The first to be discovered and the most widely
studied of these biological roles is its expression in the
chief cells of the parathyroid gland and the regulation of
parathyroid hormone release. The development of the drug
Cinacalcet to treat hyperparathyroidism was based on the
ability of the CaSR to suppress parathyroid hormone release
from the parathyroid gland. Cinacalcet is a positive allosteric
modulator of the CaSR. Its approval by the FDA in 2004
for the treatment of hyperparathyroidism represented the first
commercial development of an allosteric modulator of a GPCR
(Nemeth, 2013). The biochemical basis of Cinacalcet’s efficacy
in treating hyperparathyroidism with minimal side effects is
likely achieved by the extremely high level of expression of
the CaSR in the adult parathyroid gland. In addition to the
parathyroid gland, the CaSR is also widely expressed in other
tissues, and therefore its physiological functions extend beyond
controlling parathyroid hormone release. These functions
include suppression of vitamin D synthesis which lowers the
drive for intestinal Ca2+ absorption, negative modulation of
parathyroid hormone-induced phosphate excretion to raise the
serum inorganic phosphate level, and decreased osteoclastic-
dependent bone resorption (Leach et al., 2014). The CaSR’s
role in these processes are carried out by the activation of a
variety of intracellular signaling pathways including stimulation
of IP3 turnover and the release of intracellular Ca2+, the
activation of ERK and Akt, and other signaling pathways. It has
also become apparent that the CaSR is involved in additional
processes including cellular differentiation and migration, brain
development, stem cell engraftment, wound healing, and tumor
growth and metastasis. This review will focus on the role of
the CaSR in the differentiation and movement of cells, and the
mechanisms underlying these processes in the developing CNS
and in cancer. A summary of several key studies linking the CaSR
with cell migration is shown in Table 1.
THE CaSR IN HEMATOPOIETIC CELL
HOMING, AND BONE CELL
DIFFERENTIATION, AND MIGRATION
During mammalian ontogeny, hematopoietic stem cells (HSCs)
translocate from the fetal liver to the bone marrow where
hematopoiesis occurs throughout adulthood. A characteristic of
bone that likely contributes to an attractive microenvironment
for stem cells is the high concentration of calcium ions at
the HSC-enriched surface of the endosteum (the endosteum
is the thin vascular membrane of connective tissue that lines
the surface of the bony tissue that forms the medullary cavity
of long bones). In fact, the bone endosteal surface has been
shown to act as a niche for circulating CaSR-expressing HSCs
to preferentially localize to the bone (Adams et al., 2006). HSCs
prepared frommice lacking the CaSR were defective in localizing
to the endosteal niche, and additionally, HSC maturation was
altered as indicated by the observation that progenitor cells were
present in an immature form in the circulation and spleen.
Although CaSR−/− HSCs from fetal liver were normal in number
and in proliferative capability, they were highly defective in
localizing anatomically to the endosteal niche, a characteristic
that correlated with defective adhesion of the HSCs to collagen
I, an extracellular matrix protein (ECM) present in the endosteal
surface (Adams et al., 2006). Together, these results indicate that
the CaSR is responsible for retaining and adhering HSCs in close
physical proximity to the bone endosteal surface.
Additional in vitro studies have shown that CaSR stimulation
with Cinacalcet increased HSC growth in stromal cell co-cultures
(determined using the “cobblestone area-forming cell assay”
which measures progenitor cell-like and stem cell-like activities)
by promoting HSC adhesion to ECM proteins such as collagen
I and fibronectin (Lam et al., 2011). Moreover, co-stimulation of
CXCR4 (a GPCR) and the CaSR resulted in augmented in vivo
homing to the endosteal niche and engraftment capacity. This
work suggested that modulation of the CaSR might be a viable
strategy for enhancing HSC engraftment in bone marrow (Lam
et al., 2011).
The role of the CaSR in HSC homing has been further
established using a biodegradable composite biomaterial
composed of Ca2+ phosphate glass/polylactic acid which
was developed to mimic elevated Ca2+ levels surrounding
the bone microenvironment (Aguirre et al., 2012). Using
this biomaterial, Aguirre et al. (2012) demonstrated that
bone marrow-derived HSC mobilization, differentiation, and
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TABLE 1 | Summary of studies linking the CaSR and cellular migration.
Cells implicated in CaSR mediated cell
migration
Intracellular signaling pathways involved in CaSR mediated
cell migration
References
Cerebellar granule cell precursors (GCP) ERK2 and AKT mediated increase in plasma membrane
expression of β1 integrins
Tharmalingam et al., 2016
Renal carcinoma cells AKT, PLC, JNK, p38 Joeckel et al., 2014
Cardiac fibroblasts PLC, IP3 Zhang et al., 2014
Rat medullary thyroid carcinoma cells PLC, [Ca2+]i , ERK1/2 Tharmalingam et al., 2011
Human bronchial epithelial cells PLC, ERK1/2 Milara et al., 2010
Monocyte-macrophage lineage cells (RAW 264.7) (PI3K), Akt, PLC Boudot et al., 2010
Breast cancer cells (MDA-MB-231) ERK1/2, PLC Saidak et al., 2009
Gonadotropin-releasing hormone neurons (GnRH) CaSR activation promotes monocyte chemoattractant protein-1
(MCP-1) secretion which binds CC motif receptor-2
Chattopadhyay et al.,
2007
Haematopoietic stem cells (HSC) Intracellular signaling mechanism was not determined Adams et al., 2006
Murine osteoblastic cell line (MC3T3-E1) Intracellular signaling mechanism was not determined Yamaguchi et al., 1998
Murine bone marrow-derived stromal cell line (ST2) Intracellular signaling mechanism was not determined Yamaguchi et al., 1998
angiogenesis occurs via CaSR activation in the presence of
elevated extracellular Ca2+. One mechanism in which the
CaSR promotes HSC homing to the bone environment is by
increasing the expression of CXCR4 in the presence of elevated
extracellular Ca2+ (Wu et al., 2009). CXCR4 is involved in
leukocyte trafficking and antagonists of this receptor are being
developed for the treatment of inflammatory diseases, cancer,
and HIV. CXCR4 regulates homing of leucocytes, endothelial
progenitors, and bone marrow cells in response to SDF-1
present in the bone endosteal niche; here, extracellular Ca2+
acting through CaSR activation augments SDF-1 signaling
by serving as a positive regulator of CXCR4 expression to
promote stem cell mobilization and homing (Wu et al.,
2009).
The CaSR is expressed in both osteoclasts and osteoblasts, the
cells involved with resorption of the mineralized bone matrix
and cells that replace the resorbed bone, respectively (Sugimoto
et al., 1993; Marie, 2010). The dynamic balance between
osteoclasts and osteoblasts determines bone remodeling and
serum Ca2+ concentrations. Bone tissue likely has elevated Ca2+
levels compared to other tissues. However, studies reporting
actual measurements of Ca2+ in bone are sparse, typically use
microelectrode-based measurements, and differ widely in the
estimates of Ca2+ concentrations. An early study reported the
extracellular level of Ca2+ in bone to be about 27mM, and at
sites of osteoclastic bone resorption the local Ca2+ concentration
was estimated to be as high as 40mM (Silver et al., 1988). In
another analysis performed using microelectrode measurements
in bone slice cultures, the extracellular Ca2+ level was estimated
to be 2mM at sites of osteoclast mediated bone turnover (Berger
et al., 2001). However, the fact that the latter estimate was
derived from tissue slices in vitro leaves open the question of
its applicability in the intact bone. In any case, since maximum
CaSR responses are typically achieved at 2–4 mM extracellular
free calcium (Tharmalingam, 2014), even the lower of the two
estimates for bone cited above is within the range of CaSR
activation.
CaSR-expressing osteoblasts appear to utilize the CaSR as a
chemoattractant receptor to sense elevated extracellular Ca2+
at osteoclast mediated bone resorption sites. Migration of
CaSR-expressing osteoblasts to bone remodeling sites allows
replacement of the missing bone during the osteoblastic
phase of bone turnover (Sugimoto et al., 1993; Theman
and Collins, 2009). Signaling studies demonstrate that CaSR
stimulation in osteoblasts results in activation of phospholipase
C (PLC), extracellular signal-regulated kinase (ERK1/2), and JNK
signaling cascades. These CaSR-stimulated signaling pathways
contribute to osteoblast migration, differentiation and bone
remodeling (Sharan et al., 2008; Yamaguchi, 2008; Marie, 2010).
Similar to osteoblast migration, localization and homing
of CaSR-expressing osteoclast precursor cells to the bone
environment is important for initiating bone remodeling. Using
RAW 264.7 cell line derived from murine osteoclast precursor
cells, Boudot et al. (2010) demonstrated that extracellular Ca2+
mediated activation of the CaSR was crucial for migration of
these cells in a directional manner. The phosphoinositide 3-
kinase (PI3K)/Akt and PLCβ signaling pathways were identified
as mediators in the migratory effect. These results suggest that
the presumed extracellular Ca2+ gradient present in bone is an
initiating factor for the homing of osteoclast precursors, and may
play a role in the initiation of bone remodeling (Boudot et al.,
2010).
A final example of CaSR-mediated cellular migration is
illustrated by the migration of gonadotropin-releasing hormone
neurons in the hypothalamus. The CaSR is expressed in
primary cultures of gonadotropin-releasing hormone neurons
from murine basal forebrain, and in two different gonadotropin-
releasing hormone neuronal cell lines (Chattopadhyay et al.,
2007). Activation of the CaSR with elevated extracellular Ca2+
promoted gonadotropin-releasing hormone neurons to engage in
directional chemotaxis. CaSR stimulation resulted in Ca2+ influx
through N-type calcium channels and subsequent secretion
of monocyte chemoattractant protein which synergistically
promoted gonadotropin-releasing hormone neuron migration
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toward extracellular Ca2+ (Chattopadhyay et al., 2007). These in
vitro experiments were supported by studies in CaSR knockout
mice where CaSR null gonadotropin-releasing hormone neurons
showed approximately 27% fewer neurons in the final resting
position in the preoptic area of the anterior hypothalamus
compared to wild-type littermates (Chattopadhyay et al., 2007).
THE CaSR IN CANCER
An in silico analysis of GPCR gene expression profiling gleaned
from microarray data sets of non-small cell lung cancer, breast
cancer, prostate cancer, melanoma, gastric cancer and diffuse
large B cell lymphoma, indicated that the CaSR is up-regulated
in primary and metastatic cancer cells compared to normal
tissue (Li et al., 2005). Over the past 15 years many studies
have reported that the CaSR can act to either promote or
suppress tumorgenesis and metastasis depending on the cancer
type (Brennan et al., 2013). For example, in parathyroid and
colon cancers, CaSR expression is significantly reduced leading
to loss of the growth suppression when exposed to elevated
extracellular Ca2+. Activation of the CaSR in these tumors
has been reported to decrease cell proliferation and tumor
progression (Singh et al., 2013). Thus, CaSR expression decreases
the tumorigenicity of parathyroid and colon cancers. Conversely,
activation of the CaSR facilitates metastasis to bone in breast,
prostate, renal and various other invasive cancers (Brennan et al.,
2013). In addition, increased bone resorption induced by dietary
Ca2+ deficiency promotes breast cancer bone metastasis, while
increased dietary Ca2+ intake has preventative effects in colon
cancer and parathyroid tumor progression (Lipkin, 1999; Butler
et al., 2010; Macleod, 2013).
Similar to HSC homing, several types of primary tumor cells
migrate to bone tissue. Metastatic cells preferentially attach to
regions of active bone turnover and remodeling (e.g., blood,
femur, pelvis, ribcage, and skull). The CaSR is expressed in
both normal breast ductal epithelial cells and in primary breast
cancer cells. Stimulation of the CaSR has been shown to
promote the migration of several metastatic bone-preferring
breast cancer cell lines. Highly bone metastatic MDA-MB-231
breast cancer cells display more robust migration compared to
theMCF7 and T47D breast cancer cells, which have amuch lower
metastatic potential in vivo (Liu et al., 2009). MDA-MB-231 cells
are estrogen receptor-positive while MCF-7 cells are estrogen
receptor-negative suggesting the role of estrogen responsive
factors in the control of CaSR function. Moreover, the BT474
breast cancer cells, which do not metastasize to the bone, did not
respond to CaSR stimulation. Thus, extracellular Ca2+ appears to
be a chemoattractant for bone preferring metastatic breast cancer
cells toward a Ca2+ rich environment, and importantly, the level
of CaSR expression has been shown to correlate positively with
the magnitude of breast cancer metastasis potential (Saidak et al.,
2009).
Breast cancer metastasis to bone results in increased osteolytic
activity at the site of invasion. In highly invasive MDA-MB-
231 cells, stimulation of the CaSR induces secretion of multiple
cytokines and growth factors that result in endothelial cell
migration and in vitro angiogenesis (Hernandez-Bedolla et al.,
2015). These effects were inhibited by anti-CaSR blocking
monoclonal antibodies and the calcilytic (CaSR antagonist) NPS-
2143. The CaSR was also shown to mediate a pro-angiogenic
environment at the site of invasion by promoting the secretion
of pleiotropic molecules such as GM-CSF, EGF, MDC/CCL22,
FGF-4, and IGFBP2, which are characteristic chemotactic and
angiogenic factors. Conversely, constitutive secretion of IL-
6 and β-NGF was partially inhibited by CaSR stimulation
in MDA-MB-231 cells. However, in normal mammary cells,
constitutive secretion of RANTES, angiogenin, and oncostatin
M was attenuated by CaSR activation, whereas secretion of IL-6
was increased. Thus, altered secretion of chemotactic and pro-
angiogenic cytokines in breast cancer cells is modulated by the
CaSR (Hernandez-Bedolla et al., 2015).
The CaSR also modulates breast cancer metastasis by
mediating the secretion of parathyroid hormone-related peptide
(PTHrP). During lactation, activation of the CaSR in normal
mammary epithelial cells down-regulates PTHrP in milk and
in the circulation, and increases Ca2+ transport into milk.
However, a switch in CaSR G-protein usage during malignant
transformation appears to convert this feedback loop into a
PTHrP feed-forward cycle in breast cancer cells that exacerbates
the growth of osteolytic skeletal metastases (Vanhouten and
Wysolmerski, 2013). CaSR stimulated secretion of PTHrP from
breast cancer cells promotes osteolytic activity and is increased
by transforming growth factor-β released from resorbed bone.
Hence, in PTHrP-secreting breast cancers that metastasize to
bone, the CaSR initiates a vicious cycle in which PTHrP-
induced bone resorption raises the concentration of extracellular
Ca2+ and transforming growth factor-β within the bone
microenvironment, which then act in concert to evoke further
PTHrP release and worsening osteolysis (Sanders et al., 2001). In
some clinical cases, humoral hypercalcemia of malignancy occurs
when secretion of PTHrP by cancer cells causes hypercalcemia in
the absence of skeletal metastases (Sanders et al., 2000).
In contradiction to the studies described above demonstrating
CaSR expression up-regulation in breast cancer progression,
another study of CaSR protein expression in 148 cases of
breast cancer using tissue microarray by immunohistochemistry
reported lower CaSR expression in breast cancer lesions
compared with paired non-tumor tissues (Li et al., 2014). A
multivariate analysis showed that CaSR was of independent
prognostic significance for both overall survival and cause-
specific survival of breast cancer patients; the patients with
lower expression of CaSR were also significantly associated with
distant metastasis-free survival. Therefore, this dataset suggested
a tumor suppressor role of the CaSR in breast cancer (Li et al.,
2014). In summary, most but not all of the evidence favors a role
of the CaSR in facilitating breast cancer metastasis; additional
confirmatory studies need to be conducted looking at levels of the
CaSR in human breast cancer biopsy samples in order to validate
the findings of immortalized breast cancer cell models described
above.
Similar to metastatic breast cancer cells, prostate cancers
also metastasize primarily to skeletal regions suggesting that
the elevated extracellular Ca2+ environment of the bone may
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provide a favorable niche for its localization and progression.
In two highly metastatic prostate cell lines (PC-3 and C4-
2B cells), elevated CaSR expression and increased proliferation
was demonstrated compared to a non-skeletal metastatic,
epithelial-derived prostate cell line (Liao et al., 2006). CaSR
knockdown resulted in reduced PC-3 cell proliferation in vitro
and reduced metastatic progression in vivo. The positive effect
of CaSR activation on PC-3 cell proliferation was due to
increased inhibition of cyclic AMP accumulation and elevated
expression of cyclin D1, a protein required for cell cycle
transition. Additionally, the effects of CaSR activation of PC-
3 cell attachment and migration were attributed to activation
of the Akt signaling pathway (Liao et al., 2006). Moreover, in
human prostate cancer tissue sections and microarrays, CaSR
expression was reported in both normal prostate and in primary
prostate cancer samples as assessed by immunohistochemistry—
but metastatic prostate cancer tissue obtained from bone had
higher CaSR expression than primary prostate cancer tissue
(Feng et al., 2014). Importantly, CaSR expression in primary
prostate cancers of patients with metastases to tissues other than
bone was not different from that in primary prostate cancer
of patients with or without bony metastases. CaSR expression
in cancer tissue was not associated with the stage or status of
differentiation of the cancer (Feng et al., 2014). Taken together,
these results suggest that the CaSR may have a role in promoting
metastasis of prostate cancer to bone.
A link has also been indicated for the CaSR in renal carcinoma
metastasis. To assess the role of the CaSR in kidney cancer,
(Joeckel et al., 2014) distributed 33 matched specimens of
normal and tumor tissue and 9 primary cells derived from renal
cell carcinoma patients into three categories: non-metastasized,
metastasized into the lung, and metastasized into bones during
a 5-year period after nephrectomy (Joeckel et al., 2014). Thirty
percent of renal cell carcinomas resulted in bone metastasis.
Transcript and protein expression analysis showed the highest
CaSR expression in samples obtained from patients with bone
metastases. Ca2+-induced enhancement of renal cell carcinoma
cell migration and proliferation were only identified in cells
obtained from patients with bone metastases and absent in the
other two groups. Analysis of intracellular signaling mechanisms
of metastasizing carcinoma cells revealed that CaSR activation
resulted in enhanced activity of Akt, PLCγ-1, p38α, and JNK
signaling pathways, whereas PTEN expression was abolished.
Based on these intriguing findings, it was suggested that CaSR
expression levels could be utilized as a novel prognostic marker
for predicting renal carcinoma cell bone metastasis (Joeckel et al.,
2014).
THE CaSR AND CELL ADHESION
PROTEINS—THE INTEGRINS
Integrin Expression, Activation, and
Bi-Directional Signaling
Our previous work delineated a novel interaction between the
CaSR and a class of cellular adhesion proteins known as the
integrins (Tharmalingam et al., 2011). Identification of the
integrins as CaSR interacting proteins was initially determined
in rat thyroid carcinoma cells from CaSR immuno-affinity
pull-down experiments combined with mass spectrometry.
Pharmacological stimulation of the CaSR using the positive
allosteric modulator NPS R-568 potently enhanced thyroid
carcinoma cell adhesion and migration. Evidence that these
effects occurred via the integrins was indicated by the
demonstration that the enhancement of cell-ECM adhesion
by NPS R-568 could be largely blocked by the addition
an integrin blocking peptide (GRGDSP) that competes with
fibronectin for β1-integrin binding. Additional confirmation
was obtained whereby shRNA-mediated knock down of β1-
containing integrins reduced CaSR-mediated cell adhesion and
migration. We concluded that (a) the CaSR is associated with
β1-containing integrins in a macromolecular protein complex
and (b) that stimulation of the CaSR promotes cell adhesion and
migration via integrin activation (Tharmalingam et al., 2011).
The integrins are a family of proteins that mediate cell-
to-cell contact by binding to the ECM. Integrins are cell
adhesion molecules that interact with the ECM to provide a
dynamic link between the extracellular adhesion molecules and
the intracellular actin cytoskeleton. These proteins are unique
in that they are able to bind to ECM proteins and induce
intracellular signaling cascades, and are also capable of conveying
intracellular signaling messages to the ECM by modulating their
binding affinity for the ECM. Bymediating cell-ECM interactions
integrins play an essential role in cellular migration. They
are also involved in other cellular processes including cellular
differentiation, proliferation, embryogenesis, CNS development,
inflammation and cancer (Iwamoto and Calderwood, 2015;
Maartens and Brown, 2015; Wang et al., 2015).
Integrins are heterodimers of type 1 membrane-spanning
glycoproteins composed of an α and a β subunit (Figure 1).
In mammals, there are 18 α and 8 β subunits that form 24
heterodimeric pairs (see Campbell and Humphries, 2011 and
Maartens and Brown, 2015 for reviews). Both α and β integrin
subunits are characterized by a very large extracellular domain
of 700–1100 residues, a single transmembrane domain, and a
short cytoplasmic domain of 30–50 residues, with both subunits
held together via non-covalent interactions. The outermost
N-terminal region of the α integrin subunit that faces the
extracellular side of the cell is composed of a head structure with
seven-bladed β-propellers, which connects to the leg structure
composed of a thigh, calf-1 and calf-2 domains (Barczyk et al.,
2010). A region between the thigh and calf-1 domain known as
the “α subunit genu” acts as a pivot point for integrin domain
extension.
In the resting state integrins adopt a conformation where
the integrin leg structures are severely bent, generating a closed
topology where the head domain are juxtaposed to the leg regions
close to the cell membrane (Figure 1). In this conformation
the integrin ligand binding sites are not optimal for binding
ECM proteins, and therefore the bent conformation represents
a low-affinity state. The presence of ECM ligands induces an
intermediate-affinity conformation in which a switch-blade like
extension of the head region shifts away from the legs (Luo
and Springer, 2006; Barczyk et al., 2010). Destabilization of the
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FIGURE 1 | Integrin structure and bidirectional signaling. Integrins are membrane-spanning glycoprotein heterodimers that mediate cell adhesion and migration.
The large extracellular domains contain sites for ligand and cation binding, while the small intracellular region senses changes in intracellular signaling pathways that
convey information to the ECM via conformational modifications. Inactive integrins are present in a bent conformation (low affinity, left). Intracellular activation signals
induce integrins to attain an upright position with a dual extended head-piece arrangement (middle). The upright conformation is characterized by an intermediate
affinity state and a high affinity, ligand-bound state where the integrin α and β subunit tails are separated. Integrin inside-out signaling is achieved when intracellular
signaling proteins push the β integrin leg away from the α integrin subunit, allowing for formation of an integrin high affinity activation state (right). Stabilization of
integrin binding to ECM initiates outside-in signaling, where the integrins mediate downstream signaling that includes focal adhesion and actin stress fiber formations,
activation of Rho GTPases, and cellular structural changes, etc., which ultimately leads to promotion of cell adhesion and migration.
α/β integrin association fully activates the integrins into a high-
affinity conformation (O’Toole et al., 1991; Lu et al., 2001),
and transmembrane domain separation is necessary for integrin
signaling (Wang and Luo, 2010).
From the intracellular side, integrins do not bind actin
directly, but rather indirectly by proteins they recruit with their
cytoplasmic tails. The dynamic complex of proteins at cell–ECM
adhesions has been termed the integrin adhesome. A crucial
adhesome component is the cytoskeletal-associated protein talin,
which can simultaneously bind the cytoplasmic tail of integrin β
subunits and actin, as well as coordinate the solicitation of other
proteins to the adhesome (Critchley, 2009). Integrin inside-out
signaling is mediated by the binding of talin to the β integrin
C-terminal tail, a process that is controlled by the small GTPase
Rap1 and its effectors such as RapL and RIAM (Mehrbod et al.,
2013). Rap1 is activated by various GPCRs that are activated by
chemoattractant stimulation. Stimulation ofmembrane spanning
receptors mediates cell adhesion and migration by activating
signaling cascades that lead to integrin inside-out signaling
(Mehrbod et al., 2013). Upon separation of the integrin α and β
subunits, the integrins adopt a high affinity active conformation
that allows binding of ECM proteins. Ligand (ECM) occupancy
and integrin clustering in-turn activates intracellular signaling
cascades that mediate cell cytoskeletal changes, a process known
as integrin outside-in signaling (Figure 1).
Upon binding to ECM proteins, integrin dimers cluster
together laterally on the membrane via cell surface insertion of
integrins localized in caveolae-rich microdomains (Maheshwari
et al., 2000). Integrin clustering induces actin filament assembly
and reorganization of actin filaments into larger stress fibers
in turn causes further integrin clustering, providing a positive
feedback loop that maintains enhanced matrix binding. The
aggregation of ECM proteins, integrins, cytoskeletal proteins,
and signaling kinases forms unique structures known as focal
adhesion complexes (Parsons et al., 2010). In particular, integrin
ligation and clustering activates focal adhesion kinase (FAK),
which in-turn activates Src-family kinases (Mitra and Schlaepfer,
2006; Hu and Luo, 2013). Activated Src phosphorylates
cytoskeletal proteins such as paxillin, actin bundling protein
α-actinin and vinculin to form nascent adhesion structures.
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Binding of these initial cytoskeletal proteins recruits further actin
nucleating proteins that result in focal adhesion complex and
actin stress-fiber formation. These cytoskeletal changes mediated
by integrin outside-in signaling ultimately allow cells to adhere
and spread over the ECM proteins.
Intriguingly, and also similar to the CaSR, the integrins
contain multiple divalent cation binding sites in the extracellular
domain (Xiong et al., 2002). The integrin cation binding sites
can be occupied by Ca2+ or by Mn2+ ions. However, the
integrins differ from the CaSR in that the cations are necessary
but not sufficient for integrins to convert from the inactive
bent conformation into the active extended conformation. Both
the presence of cations bound to the multiple cation binding
sites is required, along with the direct physical association with
ECM ligands for integrins to attain the extended structure and
concomitant activation (Dai et al., 2015). Based on these features,
we hypothesize that a rise in extracellular Ca2+ ions would serve
to both prime the integrin heterodimer and activate the CaSR (see
further discussion below).
Integrins are crucial players in several aspects of bone tissue
biology (see Marie et al., 2014 for review). Several integrin
heterodimers including α5β1 integrin, α2β1 integrin, and α4β1
integrin have been shown to play important roles in bone
formation and maintenance, and in bone cell differentiation
(Hamidouche et al., 2009; Guan et al., 2012; Marie, 2012).
In general, activation of integrins on osteoblasts leads to
cell differentiation. In bone (and other tissues) ECM–integrin
binding induces the recruitment and phosphorylation of focal
adhesion kinase and activation of phosphatidylinositol 3-kinase
(PI3K) and mitogen-activated protein kinase (MAPK) ERK1/2,
leading to activation of the transcription factor RUNX2 and
osteoblast differentiation.
Of special interest here in light of the identification of the
CaSR- β1 integrin complexes, is that β1-containing integrins
play an important role in osteoblast differentiation. Direct
evidence supporting this concept comes from mice expressing
a dominant-negative β1 integrin subunit in mature osteoblasts.
These mutant mice show reduced bone mass, defective bone
formation and loss of ICAP-1, an important modulator of β1
integrin activation resulting in defective osteoblast differentiation
and delayed bone formation (Globus et al., 2005; Brunner
et al., 2011). The a5β1 integrin heterodimer which binds to the
ECM protein fibronectin, is essential for osteoblast formation,
and α5 integrin suppression reduces osteoblast differentiation,
whereas its overexpression facilitates osteoblast differentiation in
cultured mesenchymal skeletal cells. These effects are mediated
via FAK/MAPK ERK1/2 signaling (Hamidouche et al., 2009).
It has also been shown that integrin αvβ3 is critical for
CYR61-mediated BMP-2 expression and subsequent osteoblastic
differentiation through activation of the ILK/MAPK ERK1/2
signaling pathway in osteoblasts (Su et al., 2010). Similarly, α2β1,
a major receptor for collagen type 1, was reported to control
collagen synthesis in osteoblasts in mice (Stange et al., 2013).
This integrin heterodimer plays a role in mesenchymal skeletal
cells osteogenic differentiation and survival through activation
of ROCK, FAK, and MAPK ERK1/2 signaling. Together, these
findings provide insight into the role of integrin-mediated
signaling pathways in the control of osteoblast differentiation,
fate, and function (Marie et al., 2014).
Integrins and Metastasis
Integrins have been intensively studied in the context of cancer
with hundreds of literature citations on the topic; therefore, we
will restrict our discussion here to the most pertinent findings on
the association of β1-containing integrins andmetastasis to bone.
β1 integrins are activated in metastatic prostate cancer cells
and mediate increased prostate cancer cell metastasis to lymph
nodes and bone. Dissemination of prostate cancer cells to the
bonemarrow occurs early in the disease. Cancer cell proliferation
and active metastases after a period of undetectable disease is
known as tumor dormancy. Dormancy-reactivation has been
studied in patient-derived xenograft lines where the propensity
to proliferate through tumor cell contact with each other, and
with bone marrow stroma was demonstrated (Ruppender et al.,
2015). Proliferating prostate cancer cells displayed tumor cell-
cell contact and integrin clustering after ECM contact (e.g.,
fibronectin) in bone marrow stroma. Activation of myosin light
chain kinase, a downstream effector of integrin-β1 and TGF-
β2, in non-proliferating cells promoted cell proliferation. This
activity leads to the deactivation of growth suppressor like E2F4
and activation of cell cycle regulator CDK6 thereby promoting
cell proliferation (Ruppender et al., 2015). These data illustrate
the involvement of integrins in the escape of prostate cancer cells
from dormancy.
Similar to CaSR expression in metastatic prostate cancers,
β1-containing integrins have been shown to be constitutively
activated in prostate cancer cell lines with high metastatic
potential, but not in cancer cell lines with lowmetastatic potential
(Lee et al., 2013).Activation of β1 integrins promotes resistance
to anoikis. Anoikis is a form of programmed cell death that
is induced by anchorage-dependent cells detaching from the
surrounding ECM. Usually cells stay close to the tissue to which
they belong since the communication between proximal cells
as well as between cells and ECM provide essential signals for
growth or survival. When cells are detached from the ECM,
there is a loss of normal cell–matrix interactions, and they
may undergo anoikis. However, metastatic tumor cells may
escape from anoikis and invade other organs. Resistance to
anoikis occurs via stimulation of FAK/Akt-mediated survival
pathway and neutralizing β1 integrin activation using an anti-
β1 integrin antibody reduced prostate cancer metastasis in vivo
(Lee et al., 2013). In addition, talins which are adaptor proteins
that regulate focal adhesion signaling by conjugating integrins
to the cytoskeleton, bind integrins and are essential for integrin
activation. In this context, talin has been shown to be important
for β1 integrin activation, and Cdk5-mediated phosphorylation
of talin leading to β1 integrin activation was shown to increase
the metastatic potential of prostate cancer cells (Jin et al., 2015).
Integrins are also involved in breast cancer metastasis. Bone
metastasis affects more than 70% of advanced breast cancer
patients, but the underlying molecular mechanisms remain
unclear. Although some evidence suggests that integrins mediate
adhesion of malignant cells to bone ECM, their role during bone
colonization is also not fully understood. The role of β1 integrins
Frontiers in Physiology | www.frontiersin.org 7 May 2016 | Volume 7 | Article 190
Tharmalingam and Hampson Calcium-Sensing Receptor and Integrins
in bone colonization has been investigated in vitro and in
vivo in tissue-engineered humanized bone models (Thibaudeau
et al., 2015). In vitro, bone- metastatic breast cancer cells with
suppressed integrin β1 expression showed reduced attachment,
spreading, and migration within human bone matrix compared
to control cells. Cell proliferation in vitro was not affected
by β1 integrin knockdown, but tumor growth in vivo within
humanized bone microenvironments was significantly inhibited
upon β1 integrin suppression. Tumor cells invaded bone marrow
spaces in the humanized bone and formed osteolytic lesions
whereas osteoclastic bone resorption was, however, not reduced
by β1 integrin knockdown (Thibaudeau et al., 2015). These
observations indicate that β1-containing integrins likely play a
prominent role in bone colonization.
Some data are also available linking integrins and bone
metastasis in renal carcinomas. Renal carcinoma cells that form
bone metastasis constitutively activate osteoclasts, which then
induce bone resorption and release pro-proliferative factors. As
noted above, this phenomenon also occurs in bone metastasis
of other types of tumors including breast and prostate cancer.
Constitutive activation of osteoclasts leads to the release
of fibronectin and collagen which can facilitate cancer cell
attachment via integrins to ECM and vascular endothelial cells.
Cell adhesion of bone metastasizing cells to fibronectin and
to collagen I (but not adhesion to collagen IV) is high and
bone has a high concentration of these two ECM proteins (Ode
et al., 2010). In one study, 9 renal cell carcinoma primary cell
lines and 30 renal cell carcinoma tissue specimens (normal
and tumor tissue) collected from 3 patients with no metastasis,
and 10 samples with lung or bone metastasis within 5 years
after nephrectomy were collected and analyzed (Haber et al.,
2015). Compared to renal cell carcinoma cells from patients
without metastasis, the migration of cells from patients with bone
metastasis was enhanced 14-fold, and adhesion to fibronectin and
collagen I were both enhanced 6-fold. Notably, proliferation was
decreased in metastasizing cells. In addition, elevated activity of
Akt and FAK and integrin α5 expression, and reduced PTEN
expression was observed in primary cells from patients with bone
metastasis compared to non-metastasizing cells. Thus, (Haber
et al., 2015) concluded that increased expression of integrin α5
and downstream signaling via Akt could help tumor cells to
adhere to ECM proteins and facilitate migration to bone tissue.
In summary, three lines of evidence lend support to the
hypothesis that CaSR-integrin complexes may be a factor in
some forms of cancer metastasis: (1) the findings outlined
above and others indicating a role for β1-containing integrins
in cancer metastasis to bone, (2) the considerable body of
evidence demonstrating elevated CaSR expression in prostate,
breast, and kidney cancers that metastasize to bone, and (3)
the presence of CaSR-β1 integrin macromolecular complexes
in thyroid carcinoma cells (Tharmalingam et al., 2011). We
postulate that in circulating tumor cells, CaSR-integrin protein
complexes could function together as a cell surface detection
mechanism for attaching to the ECM components of the bone
microenvironment (Figure 2). The CaSR could act as the calcium
sensor and become activated by the (presumed) high extracellular
Ca2+; in bone tissue this would be followed in turn by activation
of the associated integrins on the tumor cell to signal attachment
to bone ECM proteins such as fibronectin and collagen. It
should be emphasized that this proposed sequence of events is
speculative and further work is needed to rigorously test the
idea.
FIGURE 2 | CaSR and integrins in cancer metastasis to bone. The diagram illustrates a proposed multi-step process whereby primary tumor cells enter the
vasculature and colonize resorbing regions in bone. Tumor cells with elevated CaSR and integrin expression intravastates blood vessels and circulate in the
bloodstream. Resorbing bone houses osteoclasts which release Ca2+; elevated extracellular Ca2+ is detected by the CaSR which activates integrin heterodimers to
promote binding to ECM proteins such as collagen and laminin.
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THE CaSR AND INTEGRINS IN THE
DEVELOPING CNS
Developmental Expression of the CaSR
and Integrins in the CNS
CaSR expression in the central nervous system (CNS) was
first demonstrated using a rat striatal cDNA library where
it was determined that the receptor is expressed in both
neurons and glia (Ruat et al., 1995). In adults, the CaSR is
localized to nerve terminals with discrete punctate expression.
Upon depolarization, the synaptic space contains elevated Ca2+.
Due it is localization within nerve terminals, the CaSR may
regulate neurotransmitter disposition in response to synaptic
Ca2+ changes (Ruat et al., 1995; Ruat and Traiffort, 2013).
In the immature brain the receptor is expressed in several
regions including the orbital cortex, cerebellum (see below), and
hippocampus (Ferry et al., 2000; Tharmalingam et al., 2016).
Analysis of rat hippocampal mRNA and protein expression
showed that peak CaSR expression occurs from postnatal day
12 to day 24, followed by a 3-fold decrease to adult levels
(Chattopadhyay et al., 1997). Cellular analysis demonstrated
CaSR expression in pyramidal cells of all the layers of
hippocampus and in granule cells of the dentate gyrus.
Studies on of CaSR knockout mice during postnatal brain
development have indicated that the CaSR plays an important
role in the differentiation of numerous brain cell types. For
example, CaSR null mice exhibited developmental delay due
to impaired differentiation as assessed by reduced expression
of proliferating cell nuclear antigen, neuronal specific nuclear
protein (neuronal differentiation marker), glial fibrillary acidic
protein (glial differentiation marker), and myelin basic protein
(oligodendrocyte differentiation marker) when compared to age-
matched wild-type littermates (Liu et al., 2013). Brain weight
and size were drastically reduced in the CaSR null mice and
cell proliferation was also decreased in the CaSR knockout
animals. Concurrent deletion of the CaSR with parathyroid
hormone gene corrected for the effects of hyperparathyroidism,
hypercalcemia, hypophosphatemia, and whole-body growth
retardation (Liu et al., 2013). However, further analysis of these
animals established that brain cell proliferation was normal
whereas differentiation was greatly reduced in the CaSR-PTH
double knockout animals. The role of the CaSR in differentiation
vs. proliferation was also investigated using cultured neural
stem cells derived from the subventricular zones of CaSR null
neonatal mice, which exhibited normal proliferation capacity but
decreased differentiation capacity when compared with wild-type
animals (Liu et al., 2013). Taken together, the CaSR is crucial
for differentiation of neurons, glia and oligodendrocytes. Delayed
brain development in CaSR null newborn mice is therefore the
result of direct effects of the CaSR on cell differentiation, and
indirect CaSR effects on cell proliferation via dysregulation of
parathyroid hormone secretion and serum Ca2+ (Liu et al.,
2013).
The CaSR expression pattern in adult rodent brain differs
substantially from the immature brain. The regions of moderate
to high expression during development do not express the
receptor, or express it at very low levels, in the adult rodent
brain. However, the CaSR is expressed in a few regions of the
adult CNS including the olfactory bulbs, area postrema, and the
subfornical organ (Ferry et al., 2000; Yano et al., 2004). The
subfornical organ is a hypothalamic thirst center; its neurons
project onto supraoptic and paraventricular nuclei where they
control the activity of vasopressin-secreting neurons (Ruat and
Traiffort, 2013). Expression in the subfornical organ suggests
that the receptor is also involved in central fluid and electrolyte
balance (Yano et al., 2004). The adult cerebral arteries also
display an intense network of CaSR immunoreactive fibers
demonstrating possible functional role in vessel innervation.
Studies on adult CaSR neuronal expression have determined
that the CaSR controls neuronal excitability by regulating ion
channel function (Phillips et al., 2008; Vyleta and Smith, 2011).
These findings reinforce the idea that the CaSR modulates Ca2+-
dependent neuronal functions in both the immature and in the
adult brain.
β1 integrins are expressed in all cell types in the CNS
and integrin heterodimers containing the β1 integrin are
indispensable for many functions in the brain where the
β1 subunit forms obligate heterodimers with numerous α
integrin subunits to create functional receptor complexes.
Each brain region and cell type expresses its own repertoire
of α integrin subunits resulting in different integrin receptor
expression profile and function (reviewed by Pinkstaff et al.,
1999). In the developing nervous system, spatial and temporal
changes in integrin expression parallel changes in neurogenesis,
differentiation, and migration (Schmid and Anton, 2003).
In early CNS development, neuronal migration during
establishment of the cerebral and cerebellar cortex requires
β1 integrin-mediated adhesion and migration (Hatten, 1999).
Neurons originating from the ventricular zone migrate radially
using glial cells and detach from the glial fibers at the cortical
plate to establish connections at their final resting position.
Loss of β1 integrins in neurons results in grossly disorganized
structures in the most superficial layer of the cortex (Milner
and Campbell, 2002), and selective deletion of β1 integrins in
glia resulted in failure of glial cell contact formation with the
meningeal basement membrane and blocked neuronal radial
migration (Blaess et al., 2004; Frick et al., 2012). Therefore,
normal assembly of the cerebral and cerebellar cortex requires β1
integrin mediated neuronal migration and glial adhesion (Milner
and Campbell, 2002).
CaSR-Integrin Complexes in Cerebellar
Development
The well-established migrational patterns of immature cerebellar
granule-cell precursor neurons (GCPs) in the early postnatal
cerebellum provides an excellent model system to delineate the
molecular properties of neuronal migration. GCPs originate
in the rhombic lip during late embryonic stages and then
migrate rostrally to a secondary germinal layer, known as
the external granule-cell layer of the cerebellum, where they
continue to proliferate after birth. In rodents GCPs proliferate in
the periphery of the external granule layer-cerebellar basement
membrane interface over postnatal days 5–20 (Figure 3).
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Various factors such as laminin (expressed on the basement
membrane), sonic hedge-hog (released from Purkinje cells),
brain-derived neurotropic factor (released from Bergmann glia),
and insulin-like growth factors contribute to GCP proliferation.
GCPs that have proliferated and exited the cell-cycle undergo
tangential migration within the external granule layer (Figure 3).
Tangentially migrating GCPs attach to the Bergmann glial
processes and undergo radial migration whereby the GCPs
migrate radially along the Bergmann glia fibers through the
cerebellar molecular layer and the Purkinje cell layer, and into
their final resting position in the internal granule-cell layer
(Chedotal, 2010). By 3 weeks after birth GCP proliferation ceases
and the remaining GCPs complete migration into the internal
granule layer, which is retained in the mature brain while the
external granule layer disappears. In the adult CNS cerebellar
granule cells are the most numerous class of neurons in the
vertebrate brain.
The role of β1 integrins in cerebellar GCP proliferation and
migration has been well documented. Potent stimulants of GCP
proliferation such as sonic hedgehog and SDF-1 have been
shown to induce GCP proliferation only in the presence of β1
integrin mediated adhesion to laminin (Klein et al., 2001; Blaess
et al., 2004). β1 integrins control GCP migration by binding to
ECM proteins such as laminin, vitronectin, reelin, etc., which
aid in the homing of GCPs from the external granule layer to
the internal granule layer (Pons et al., 2001; Borghesani et al.,
2002; Porcionatto, 2006). Thus, GCP migration relies heavily on
integrin activation. Notably, defects in GCP migration result in
medulloblastoma, the most common cause of malignant brain
tumors in young children (see below).
We have recently demonstrated that the CaSR, together
with integrins, functions as a cell-surface chemoattractant
receptor expressed on the surface of cerebellar GCPs to
facilitate GCP differentiation into mature granule cells, and
to simultaneously guide their movement during cerebellar
maturation (Tharmalingam et al., 2016). A robust but transient
increase in CaSR expression in GPCs was observed that peaked
during the second postnatal week, the period of maximal GPC
migration. Our results support a model whereby the CaSR acts
as a chemoattractant sensor to detect a gradient of extracellular
Ca2+, while integrin heterodimers in conjunction with ECM
proteins function as the driving force to mediate cell movement
(Tharmalingam et al., 2016). The data also indicated that
CaSR-mediated stimulation of ERK2 and Akt phosphorylation
provides a biochemical link between Ca2+-sensing and the
integrin-mediated movement of GCPs (Figure 5; also see further
discussion below).
A key question to be addressed is, what is the source of
the CaSR stimulus in the immature cerebellum? One possibility
is that activation of the CaSR may be mediated by local
FIGURE 3 | Cerebellar development and GCP migration (adapted from Tharmalingam, 2014). GCPs (blue spheres, top) proliferate in response to growth
signals including sonic hedgehog (shh) released by Purkinje cells (PC, purple). Mitotic GCPs exit the cell cycle to become migratory post-mitotic bipolar GCPs (orange)
that undergo tangential migration in the external granule-cell layer (EGL). The bipolar migratory GCPs sprout a third process and attach to Bergmann glia (BG) fibers
(red) to undergo radial migration through the molecular layer (ML) and the Purkinje layer (PL), and into the internal granule-cell layer (IGL; mature granule neurons, dark
orange). GCPs undergo radial migration by sensing extracellular matrix cues (laminin, vitronectin, etc.) and radially expanding transglial Ca2+ waves (pink circles)
released by Bergmann glial processes.
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extracellular Ca2+ released by the Bergmann glia. Tangentially
migrating unipolar GCPs in the external granule layer sprout
a third axon that allows the GCPs to attach to Bergmann
glial fiber tracts to undergo radial migration into the internal
granule layer. Bergmann glial fibers have been shown to
generate radially expanding transglial Ca2+ waves that initiate
at a central point and expand radially to encompass multiple
Bergmann glial processes (Hoogland et al., 2009). The Ca2+
waves generated by Bergmann glia could locally activate the
CaSR expressed on GCPs to promote radial migration. Another
potential source of CaSR activation may be from polyamines.
Polyamines such as spermine and spermidine are potent agonists
of the CaSR and polyamine concentrations are elevated during
postnatal cerebellar development and then subsequently decline
to adult levels (Jasper et al., 1982). The period of increased
polyamines corresponds to the peak period of CaSR expression
and GCP migration. Moreover, the initial step in the synthesis
of the polyamines is mediated by the enzyme ornithine
decarboxylase. In the cerebellum of rats injected with α-
difluoromethylornithine, an inhibitor of ornithine decarboxylase,
granule cells fail to migrate properly and the development of
the cerebellar cortex is stalled in an immature state (Bartolome
et al., 1985). Taken together these findings indicate that
polyamines might act alone, or in conjunction with Ca2+ ions, to
stimulate the CaSR and guide GCP migration in the developing
brain.
Cerebellar Granule Cells and
Medullablastoma
Defects in GCP migration result in medulloblastoma, the most
common cause of malignant brain tumors in children under
four (Hatten and Roussel, 2011; Remke et al., 2013; Macdonald
et al., 2014). Medulloblastoma is a highly heterogeneous group
of tumors characterized by aberrant GCP proliferation and
migration. Unlike most neuronal populations, GCPs remain
mitotically active after birth (Roussel and Hatten, 2011).
Impaired migration causes GCPs to remain longer in the
proliferative-niche of the external granule layer where they are
more prone to transformational insults due to increased exposure
to proliferation-inducing molecules. There are currently no
effective treatments for medulloblastoma. Although a role for
the CaSR in medulloblastoma has not been established, the
identification of key proteins regulating GCP migration and
progression is a major goal in medulloblastoma research, and
could lead to novel approaches for the development of effective
therapeutics.
Medulloblastoma has been modeled in vitro using DAOY
cells which are transformed human cerebellar granule cells. Wei
et al. (2015) studied the function of the CaSR in these cells and
compared them to normal cerebellar granule cells in culture
(Wei et al., 2015). They examined the CaSR in conjunction
with OGR1 (also known as GPR68), an extracellular proton-
sensing GPCR coupled to Gq and the release intracellular
Ca2+. In addition to protons, this receptor is also activated by
the benzodiazepine anxiolytic drug lorazepam (Huang et al.,
2015). Previous work had established that OGR1 activation in
DAOY cells leads to complex intracellular Ca2+ signals and
activation of the ERK signaling pathway, thereby providing a
mechanistic explanation of how the acidic environment may
influence transformed cell function and/or survival. This action
is lost on differentiation, suggesting a link between OGR1 activity
and proliferative behavior of the transformed neurons (Huang
et al., 2009). Curiously, Ca2+ signaling through OGR1 and
CaSR appears to be opposite in the two cell types. In normal
granule cells, OGR1-dependent Ca2+ signaling is slow and small
while CaSR-dependent intracellular Ca2+ signaling is fast and
large, whereas the opposite occurs in DAOY cells (Wei et al.,
2015). It was suggested that the lack of inhibition of OGR1
signaling by CaSR in DAOY cells is likely due, at least in part,
to low expression of functional CaSR in these cells, given that
knockdown of CaSR in granule cells also leads to disinhibition of
OGR1 signaling. Moreover, CaSR-dependent inhibition of OGR1
activity is absent in DAOY cells and intracellular acidification,
which may accompany extracellular acidosis, inhibited CaSR
responses but potentiated OGR1 responses (Wei et al., 2015).
OGR1 is functionally expressed in brain tumor cells
and changes in its activity may be relevant to acidosis in
tumors. Both OGR1 and CaSR have been implicated in
several brain disorders that are exacerbated by changes in
the concentrations of extracellular H+ and Ca2+ (Kingsley
et al., 2007). The CaSR and OGR1 are also co-expressed in
other tissues that experience extracellular acidification under
physiological conditions including kidney, bone, and lung.
Therefore, in addition to cerebellar neurons, a perturbation in
the balance between OGR1 and CaSR signaling may contribute
to the development and progression of other pathological
conditions.
POTENTIAL MOLECULAR MECHANISMS
UNDERLYING CaSR-INTEGRIN
INTERACTIONS AND CELLULAR
MIGRATION
Cell migration is a multistep process that requires continuous
coordinated formation and disassembly of cytoskeletal proteins
(Webb et al., 2002). The migratory cycle progresses from
activation of a chemoattractant receptor, protrusion extension
toward a chemoattractant gradient, formation of stable adhesions
at the leading edge of the protrusions via integrin engagement
of ECM proteins, release of adhesions and retraction at the
cell rear, and the translocation of cell body forward (Figure 4).
Increased integrin-ECM ligation promotes outside-in integrin
signaling characterized by focal adhesion complex formation
and actin cytoskeletal polymerization (Vicente-Manzanares et al.,
2009). These cytoskeletal changes drive the initial protrusion
extension of the plasma membrane allowing the cell to
spread. Cell polarity is achieved when the leading edge forms
stable adhesion contacts via actin polymerization, while the
trailing edge disassembles actin formation, and stable adhesion
contacts serve as traction points for the propulsive forces that
move the cell body forward (Webb et al., 2002). Release of
integrin mediated adhesions at the rear allows translocation
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FIGURE 4 | Proposed mechanism for CaSR-integrin mediated directional cell migration toward a CaSR-agonist gradient. Step 1: under resting conditions
there is a homogenous distribution of integrins along the plasma membrane of the cell. Integrins present in the active confirmation are bound to the ECM proteins
allowing the cell to spread evenly on the ECM substratum. In the absence of CaSR agonists, the integrins present in the CaSR-integrin complex adopt an inactive bent
conformation. Step 2: exposure of the cell to a Ca2+ gradient results in CaSR-integrin mediated cell polarization. The CaSR-integrin complexes present proximal to
the Ca2+ gradient uses the CaSR to sense the stimulus allowing for localized activation of intracellular signaling pathways. Activation of CaSR triggers PLC-IP3
mediated rise in intracellular Ca2+ causing integrin inside-out activation and elevated activated integrins at the site of CaSR stimulation. CaSR activation also
promotes ERK2 and Akt-mediated trafficking and insertion of cytoplasmic endosomal integrins into the plasma membrane. Increased integrin-ECM interactions at the
leading edge establishes cell polarity by allowing the formation of adhesion contacts and actin polymerization at the migrating front, while the tailing edge
disassembles actin formation. Step 3: CaSR stimulation dependent redistribution of integrins and actin stress formation from the trailing edges to the migrating front is
important for guided cell migration. The transfer of actin fibers to the leading edge of the cell, while limiting the level of integrins, actin and microtubules available in the
retracting edge prompts directed cell migration toward the calcium gradient. The dynamic assembly and disassembly, together with actomyosin contractility moves
the cell toward the Ca2+ gradient.
of the cell in the direction of the chemoattractant gradient
(Figure 4).
The CaSR and integrins are both abundantly localized in
caveolae-rich microdomains (Breitwieser, 2013; Iwamoto and
Calderwood, 2015; Maartens and Brown, 2015). In cerebellar
GCPs, this microdomain-type expression pattern is revealed in
discrete puncta present throughout the cell cytosol. In GCPs,
activation of the CaSR resulted in increased cell migration by
promoting cell surface expression of β1 integrins, but surprisingly,
stimulation of the CaSR did not increase the cell surface
expression of the CaSR itself (Tharmalingam et al., 2016). This
observation might be attributed to trafficking mechanisms which
control receptor cell surface expression. CaSR and integrin cell
surface expression is driven by agonist stimulation, in that
activation of the surface receptor activates signaling cascades
which allows further insertion of caveolae-rich microdomain
containing receptors to the surface, thus allowing persistent
signaling in the presence of chronic agonist stimulation (Grant
et al., 2011; also see discussion below).
At the molecular level, one potential mechanism for
functional cooperation between the CaSR and integrins is via
a protein-protein interaction between the CaSR homodimer
and the integrin heterodimers within a tetrameric complex, or
as part of a larger complex containing additional proteins. A
direct protein-protein interaction would require that the CaSR
homodimer and integrin heterodimers are either physically
in contact with each other, which has not yet been directly
demonstrated, or present with additional proteins that influence
each other by conformational changes within a macromolecular
complex. In this scenario, we propose a working model whereby
an agonist-induced conformational change in the CaSR induces
flipping of the associated integrin heterodimers into an active
conformation. Both the integrins and the CaSR possess large
extracellular domains. Although no studies directly examining
conformational changes in the CaSR have been reported, other
members of this GPCR subfamily such as the GABAB receptor
and the metabotropic glutamate receptors, are known to undergo
closure of their large extracellular Venus flytrap domains
upon agonist binding (Tsuchiya et al., 2002; Pin et al., 2009).
Activation of the CaSR could directly trigger integrin activation
thereby inducing cellular adhesion, differentiation, or migration
depending on the cellular environment.
An alternative mechanism to consider is a series of
biochemical events that entail stimulation of CaSR/integrin
complexes followed by the activation of intracellular signaling
cascades. Activation of the CaSR is linked to several intracellular
signaling pathways which could modify integrin conformation
from within the cell. Our previous work in thyroid carcinoma
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cells provided evidence for an indirect mechanism in which
stimulation of the CaSR induces activation of PLC and release
of intracellular Ca2+, which in turn promotes cell adhesion
and migration (Tharmalingam et al., 2011; see Figure 5A).
Stimulation-dependent redistribution of integrins and actin
stress formation from the trailing edges to the migrating front
is important for chemoattractant-guided cell migration, and PLC
activation and the release of intracellular Ca2+ have been shown
to be important for integrin inside-out activation (Rowin et al.,
1998). Specifically, a rise in intracellular Ca2+ increases cell
adhesion and migration by specifying the location and timing of
cell process retraction (Sjaastad et al., 1996; Valeyev et al., 2006);
migrating cells display increased intracellular Ca2+ gradients
which increase toward the rear of cells (Brundage et al., 1991;
Brust-Mascher and Webb, 1998). Elevated intracellular Ca2+
has also been linked to increased contractility and adhesion
disassembly mediated by calpain, a Ca2+ dependent protease
(Doyle and Lee, 2002; Robles et al., 2003; Valeyev et al.,
2006). Thus, a CaSR-induced rise in intracellular Ca2+ may
promote integrin inside-out activation at the migrating front
while simultaneously inducing adhesion disassembly at the rear
of the cell, which then translates into cellular migration.
In contrast to thyroid carcinoma cells, CaSR-integrin actions
mediating migration of GCPs during cerebellar development
appears to be mediated not by phospholipase C, but rather
by the ERK and Akt signaling (Tharmalingam et al., 2016).
ERK2 and Akt signaling is known to promote plasma
membrane insertion of β1 integrins localized in caveolae-rich
endosomal microdomains (Maheshwari et al., 2000; Kinashi,
2005). Phosphorylation of ERK2 supports cell polarization by
controlling the proper orientation of centrosomes, an important
step for the accumulation of proteins involved in cell movement
at the leading edge of the migrating cell (Bisel et al., 2008;
Imamura et al., 2010).
FIGURE 5 | Potential mechanisms of CaSR-integrin actions in cancer cells and the developing CNS. (A) (adapted from Tharmalingam et al., 2011) depicts
one possible scenario where the CaSR is associated with integrin heterodimers in a signaling complex in thyroid carcinoma cells. Left, the complex prior to CaSR
stimulation; right, elevated extracellular calcium activate the CaSR causing its Venus flytrap domain to undergo a conformational change. This protein domain
movement may induce integrins to flip it into an activated state thereby promoting binding to the ECM and enhanced cellular migration. The “X” denotes a hypothetical
protein that may participate in facilitating the CaSR-mediated activation of integrins subsequent to increased [Ca 2+]i . (B) (adapted from Tharmalingam et al., 2016)
depicts cross-talk between CaSR (blue), integrin heterodimers (red), and intracellular protein kinases in the developing cerebellum. Left, the CaSR/integrin complex
prior to stimulation; right, elevated extracellular Ca2+ (and/or polyamines) activate the CaSR which then increases phosphorylation of ERK2 and Akt promoting β1
integrin cell surface expression. The accumulation of integrins at the leading edge of GCPs facilitates stable attachments between the GCPs and the ECM and
enhances cellular migration.
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We propose that stimulation of the CaSR activates
phosphorylation of ERK2 and Akt which then signals the
insertion of microdomains containing co-localized CaSR-
integrin complexes (Figure 5B). Upon entering the plasma
membrane, the CaSR agonists activate the newly inserted
receptors, which then transactivates the integrins which causes
engagement of ECM ligation. The ligated integrins may remain
on the plasmamembrane tomediate cell adhesion andmigration,
whereas the endocytotic mechanisms remove the CaSR from the
cell surface and degrade the receptor via lysosomal enzymes. In
this scenario, accumulation and clustering of integrins would
take place at the cell surface, whereas the CaSR would serve as
both the signal-sensing partner and as an integrin trafficking
partner in the protein complex whose net cell surface expression
may not change. In summary, in cerebellar neurons, CaSR-
mediated activation of ERK and Akt may mediate trafficking
of β1 integrins to the leading edge of the cell and facilitate the
formation of a physical link between the ECM and focal adhesion
complexes which act to promote neuronal migration.
CONCLUSIONS, IMPLICATIONS, AND
OUTSTANDING QUESTIONS
1. The CaSR and GPRC6A are close structural paralogs that are
widely expressed in many organs. Both receptors are activated
and/or modulated by cations and amino acids.
2. The CaSR and integrins share no sequence homology but both
are membrane proteins that function as dimers and possess
multiple cation binding sites. Both proteins also undergo
large conformational movements into an activated state after
agonist stimulation. CaSR/integrin protein complexes have
been identified in thyroid carcinoma cells and in cerebellar
granule cells, and may exist in other tissues and cells.
3. The CaSR has been shown to play an essential role in
cellular differentiation and migration in several cells and
tissues, and CaSR-mediated cellular migration likely occurs,
at least in some cells, via the activation of CaSR/integrin
protein complexes. In thyroid carcinoma cells, the CaSR
together with integrins facilitate cellular migration. In the
developing cerebellum, activation of the CaSR induces
neuronal differentiation and migration. Notably, stimulation
of the CaSR in cerebellar neurons did not change the level of
plasma membrane expression of the CaSR itself, but instead
promoted the trafficking of integrins to the cell surface. Thus,
it appears that cerebellar granule cell migration is mediated by
a CaSR-induced increase of integrins to the neuronal plasma
membrane.
4. In addition to thyroid carcinoma cells and cerebellar granule
neurons, the question arises as to what other cells and tissues
might utilize the CaSR/integrin system? In light of the widely
distributed expression of the CaSR in many organs and cell
types, together with the ubiquitous expression of the integrins,
could CaSR/integrin protein complexes function as a universal
cell migration/homing complex?
5. In a given tissue or cell type the physiological role of the CaSR
may change under pathological conditions. For example,
upon transformation from normal to cancerous cells, some
evidence suggests that the CaSR is associated with different
or opposite effects on cell proliferation vs. metastasis. This
phenomenon might be compatible with, or linked to, the
evolving concept that rapid cell division and proliferation
must be arrested prior to metastasis and tumor cell tissue
invasion, and that factors operating to promote either cell
division or metastatic tissue invasion might be mutually
exclusive (e.g., see Matus et al., 2015). In this context, could
stimulating CaSR activity via positive allosteric modulators or
calcimimetics hinder tumor cell proliferation, and conversely,
could inhibiting CaSR activity via calcilytics or receptor
knockdown, block or stymie cancer metastasis? This raises the
issue that the development of CaSR therapeutics as applied to
oncology could be complicated by the possibility of a CaSR
drug promoting tumor cell proliferation while inhibiting
metastasis, or vice versa. In any case, a more thorough analysis
of CaSR pharmacology, expression levels, and signaling
mechanisms in tumor cell biology could ultimately provide
solutions that translate into novel therapeutic applications.
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